In early December 2025, Twist Bioscience launched research-grade Plasmid DNA Preps with animal origin-free and endotoxin-free options tailored to stringent preclinical study requirements. This move ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

Twist Bioscience (TWST) just rolled out research grade Plasmid DNA Preps tailored for pre clinical pharma and biotech work, a small but telling move that helps explain the recent uptick in the stock.

OverviewThe global viral vector manufacturing market is projected to expand at a robust CAGR of approximately 20% over the forecast period, supported by multiple transformative forces reshaping the ...

For the second time this year, the company is laying off workers, with its Fargo campuses feeling the impact the most.

Functionalized single-walled carbon nanotubes (SWCNTs) effectively delivered the amh/amhy plasmid into all-female mandarin ...

GERMANTOWN, MD AND HOUSTON, TX / ACCESS Newswire / December 9, 2025 / uBriGene Biosciences, a global CDMO specializing in ...

Microbial communities, like those in the human gut, act as powerful engines that drive the evolution and spread of ...

Final 2025 global cohort onboarding, with applications now open for 2026WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ...

Mercy BioAnalytics, a company dedicated to reducing suffering and saving lives through the early detection of cancer, today announced the appointment of Ellen Snow as its Chief Financial Officer. Snow ...

PSQ Holdings, Inc. ("PublicSquare," or the "Company"), today announced the launch of PSQ Impact (Impact), a next-generation political fundraising platform engineered to supercharge the Conservative ...